comparemela.com
Home
Live Updates
Company Collaborations Licensing Partnering Analysis - Breaking News
Pages:
2
3
4
5
6
7
8
Company Collaborations Licensing Partnering Analysis News Today : Breaking News, Live Updates & Top Stories | Vimarsana
World Diphtheria Pipeline Research Report 2024: Commercial
Dublin, April 19, 2024 (GLOBE NEWSWIRE) The
Route of administration
University collaborations licensing partnering analysis
Diphtheria key companies
Phase of development
Company collaborations licensing partnering analysis
Product development activities
Pipeline insight
Diphtheria commercial assessment
Clinical assessment
Topics covered
Current treatment
Deal value
Company collaborations
University collaborations
Product type
Late stage products
Global Dental Pain Pipeline Developments Report 2024
Dublin, April 18, 2024 (GLOBE NEWSWIRE) The
Route of administration
Product development activities
Pain key companies
University collaborations licensing partnering analysis
Phase of development
Pipeline development activities
Company collaborations licensing partnering analysis
Dental pain
Clinical assessments catalyze market
Questions addressed
Topics covered
Pain current treatment
Spain treatment
Deal value
Pain collaboration
Company collaborations
Opioid-Induced Constipation Pipeline Insight 2024
Dublin, April 18, 2024 (GLOBE NEWSWIRE) The
Route of administration
Constipation key companies
Product development activities
Phase of development
Company collaborations licensing partnering analysis
University collaborations licensing partnering analysis
Induced constipation
Opioid induced constipation
Opioid induced constipation commercial assessment
Induced constipation clinical assessment
Topics covered
Induced constipation current treatment
Induced constipation treatment
Deal value
Induced constipation collaboration
Company collaborations
World Metastatic Prostate Cancer Drug Landscape Research
Dublin, April 18, 2024 (GLOBE NEWSWIRE) The
Eli lilly
Leuprolide mesylate
Orion pharma
Roche ipatasertib
Myovant biosciences relugolix
Cleveland biolabs
Myovant biosciences
Vifor fresenius
Johnson astrazeneca
Genentech atezolizumab tecentriq
Drug administration
Nerviano medical sciences
Progenics pharmaceuticals inc
Company collaborations licensing partnering analysis
Janssen research development
Telix pharmaceuticals
Pollen Allergy Pipeline Insight Report 2024: Clinical
Dublin, April 12, 2024 (GLOBE NEWSWIRE) The
Phase of development
Route of administration
Company collaborations licensing partnering analysis
University collaborations licensing partnering analysis
Pollen allergy key companies
Pollen allergy
Pollen allergy commercial assessment
Allergy clinical assessment
Topics covered
Allergy current treatment
Allergy treatment
Deal value
Allergy collaboration
Company collaborations
University collaborations
Allergy acquisition
vimarsana © 2020. All Rights Reserved.